2005–2010 Model Guidelines Expert Committee Roster

Revised March 28, 2008

Cardiology

Sarah A. Spinler, Pharm.D.
Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia

Clinical Toxicology

Peter A. Chyka, Pharm.D.
Professor and Associate Dean
College of Pharmacy, Knoxville Campus
University of Tennessee Health Science Center

Dermatology

Dennis P. West, Ph.D.
Vincent W. Foglia Family Research Professor of Dermatology
Northwestern University
Feinberg School of Medicine

Endocrinology

Karim Anton Calis, Pharm.D.
Clinical Specialist, Endocrinology & Women's Health
National Institutes of Health

Gastroenterology

Cynthia Kirman, Pharm.D. (Acting Chair)
Director of Pharmacy
General Motors

Hematology

Patrick A. McKee, M.D.
George Lynn Cross Professor of Medicine
The University of Oklahoma Health Sciences Center

Immunology

John Grabenstein, Ph.D., R.Ph.
Director of Scientific Affairs
Merck Vaccine Division

Infectious Diseases

Douglas W. MacPherson, M.D.
Consultant
Migration Health Consultants, Inc.

Nephrology/Urology

Gary R. Matzke, Pharm.D.
Associate Dean for Clinical Research and Public Policy
MCV/VCU School of Pharmacy

Neurology/Otorhinolaryngology/ Ophthalmology

Mitchell F. Brin, M.D.
Senior Vice President Development & Therapeutic Area Head
Allergan, LLC

Oncology

Barbara Ann Burtness, M.D.
Fox Chase Cancer Center

Psychiatry

Amy H. Schwartz, Pharm.D.
Assistant Dean and Director
University of Texas-Pan American

Pulmonology

Elliot Israel, M.D.
Director, Respiratory Therapy
Brigham and Women's Hospital

Rheumatology

David H. Campen, M.D.
Medical Director, Drug Information & Technology
Kaiser Permanente

Special Populations/Clinical Pharmacology

Joseph T. Hanlon, Pharm.D.
Professor of Medicine
University of Pittsburgh

Therapeutic Decision Making

Nancy J. Braden, M.D.
Medical Director
Mercy Care Plan